ASRT Stock Analysis: Buy, Sell, or Hold?
ASRT - Assertio Holdings, Inc. Common Stock
$22.50
0.13 (0.58%)
▲
5d:
+21.82%
30d:
+24.86%
90d:
+76.61%
WAIT
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 11, 2026
1d
Smart Money Accumulation
ASRT is down 6.2% this week, but smart money is accumulating calls. Top strike: $12 2026-06-18 with 116 OI. Call ratio: 100% View Scanner →
Strength: 8.1/10
Get Alerted When ASRT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ASRT is 16.2% above its trading range ($19.36). Market expects 9.8% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ASRT is 16.2% above its trading range ($19.36). Market expects 9.8% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$23.95
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$14.87
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ASRT is currently trading at $22.50, which is considered extended relative to its 30-day fair value range of $17.72 to $19.36. From a valuation perspective, the stock is trading at a premium (Forward PE: 8.7) compared to its historical average (6.6). At these levels, the market is pricing in 9.8% annual earnings growth.
Technical Outlook: Technically, ASRT is in a strong uptrend. The price is approaching resistance at $22.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ASRT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ASRT is in a strong uptrend. The price is approaching resistance at $22.55. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ASRT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$17.72 -
$19.36
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.0%
All Signals
- BEARISH: Price significantly overextended (+16.2% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($23.87)
- BULLISH: Expecting earnings turnaround to 9.8% growth with -57.9% revenue growth
- WARNING: Recommendation downgraded due to 16.2% overvaluation
Trading Range Analysis
30-Day Trading Range
$17.72 -
$19.36
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$18.03
Resistance Level
$22.55
Current Trend
Strong Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.69
Wall Street Target
$23.87
(+6.1%)
Revenue Growth (YoY)
-57.9%
Earnings Growth (YoY)
-18.8%
Profit Margin
-25.6%
Valuation Premium vs History
+9.8% premium
PE vs Historical
8.7 vs 6.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.8%
(market-implied from PE analysis)
1-Year Target
$24.70
(+10%)
2-Year Target
$27.13
(+21%)
3-Year Target
$29.78
(+32%)
3-Yr Target (if PE normalizes)
(PE: 9→7)
PE COMPRESSION
$22.63
(+1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: May 09, 2026 8:43 AM ET
Data refreshes hourly during market hours. Next update: 9:43 AM
Data refreshes hourly during market hours. Next update: 9:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ASRT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$186 | 66 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$96 | 65 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$149 | 52 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 54 HOLD |
